2020 IPO
Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
Sign up today and learn more about Compass Pathways Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Compass Pathways Stock
Compass Pathways will be testing the active ingredient of magic mushrooms, psylocybin, as a treatment for depression.
Funding History
January 2017 | $4.0M |
---|